Shaanxi Micot Pharmaceutical Technology Co., Ltd. (HKG:2335)
Hong Kong · Delayed Price · Currency is HKD 25.22
-0.82 (-3.15%)
Sep 10, 2026, 11:59 AM HKT
HKG:2335 Statistics
Total Valuation
HKG:2335 has a market cap or net worth of HKD 8.64 billion. The enterprise value is 7.28 billion.
| Market Cap | 8.64B |
| Enterprise Value | 7.28B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2335 has 331.74 million shares outstanding.
| Current Share Class | 280.07M |
| Shares Outstanding | 331.74M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 44.25% |
| Owned by Institutions (%) | 18.84% |
| Float | 98.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 7.82 |
| P/TBV Ratio | 7.92 |
| P/FCF Ratio | 324.63 |
| P/OCF Ratio | 307.43 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 273.44 |
Financial Position
The company has a current ratio of 9.11, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.11 |
| Quick Ratio | 9.00 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.07 |
| Interest Coverage | -2.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -23.13% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.75M |
| Employee Count | 153 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 32.44 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 31.02 |
| Average Volume (20 Days) | 432,679 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -306.21M |
| Pretax Income | -423.34M |
| Net Income | -420.73M |
| EBITDA | -302.45M |
| EBIT | -306.21M |
| Earnings Per Share (EPS) | -1.64 |
Balance Sheet
The company has 1.38 billion in cash and 1.91 million in debt, with a net cash position of 1.38 billion or 4.15 per share.
| Cash & Cash Equivalents | 1.38B |
| Total Debt | 1.91M |
| Net Cash | 1.38B |
| Net Cash Per Share | 4.15 |
| Equity (Book Value) | 1.10B |
| Book Value Per Share | 3.29 |
| Working Capital | 1.24B |
Cash Flow
In the last 12 months, operating cash flow was 28.10 million and capital expenditures -1.49 million, giving a free cash flow of 26.61 million.
| Operating Cash Flow | 28.10M |
| Capital Expenditures | -1.49M |
| Depreciation & Amortization | 3.80M |
| Net Borrowing | -61.09M |
| Free Cash Flow | 26.61M |
| FCF Per Share | 0.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:2335 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -4.87% |
| FCF Yield | 0.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |